Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium

By sjmartinez • March 21, 2025

Kishan AU, Sun Y, Tree AC, Hall E, Dearnaley D, Catton CN, Lukka HR, Pond G, Lee WR, Sandler HM, Feng FY, Nguyen PL, Incrocci L, Heemsbergen W, Pos FJ, Horwitz E, Wong JK, Hoffman KE, Hassanzadeh C, Kuban DA, Arcangeli S, Sanguineti G, Supiot S, Crehange G, Latorzeff I, Kalbasi TR, Steinberg ML, Valle LF, Loblaw A, Nikitas J, Roy S, Zaorsky NG, Jia AY, Spratt DE. Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium. Lancet Oncol. 2025 Mar 17:S1470-2045(25)00034-8. doi: 10.1016/S1470-2045(25)00034-8. Epub ahead of print. PMID: 40112848.

Tags: DOM STAT, General Internal Medicine, Publications

Emerging quantitative CCTA imaging biomarkers for cardiovascular risk stratification: a narrative review

Mora R, Irannejad K, Abbas N, Mogga P, Iskander B, Hubbard L, Roy S, Lakshmanan S, Budoff M, Krishnan S. Emerging quantitative CCTA imaging biomarkers[...]

Matching Primary Care and Integrated Mental Health Visits by Care Modality and Linkage to Same-Day Services for Veterans

Bonilla AG, Lov D, Haderlein TP, Jackson NJ, Leung LB. Matching Primary Care and Integrated Mental Health Visits by Care Modality and Linkage to Same-Day[...]

South Asian Cardiovascular Risk: Role of Coronary Artery Calcium Scoring and Computed Tomography Angiography

Kalra DK, Vedamurthy D, Hosadurg N, Goyal A, Gupta M, Pagidipati N, Slipczuk L, Dey D, Mehta A, Joshi P, Baskaran L, Wong N, Virani[...]